Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Precipio Inc

PRPO
Current price
6.78 USD 0 USD (0.00%)
Last closed 7.13 USD
ISIN US74019L5030
Sector Healthcare
Industry Diagnostics & Research
Exchange NASDAQ
Capitalization 8 893 980 USD
Yield for 12 month +13.00 %
1Y
3Y
5Y
10Y
15Y
PRPO
21.11.2021 - 28.11.2021

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut. Address: 4 Science Park, New Haven, CT, United States, 06511

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

19.00 USD

P/E ratio

Dividend Yield

Current Year

+15 197 000 USD

Last Year

+9 412 000 USD

Current Quarter

+4 599 000 USD

Last Quarter

+4 441 000 USD

Current Year

+6 018 000 USD

Last Year

+2 510 000 USD

Current Quarter

+2 277 000 USD

Last Quarter

+1 419 000 USD

Key Figures PRPO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -4 305 000 USD
Operating Margin TTM -27.22 %
Price to Earnings
Return On Assets TTM -18.98 %
PEG Ratio
Return On Equity TTM -29.22 %
Wall Street Target Price 19.00 USD
Revenue TTM 16 720 000 USD
Book Value 10.16 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 25.70 %
Dividend Yield
Gross Profit TTM 2 392 000 USD
Earnings per share -1.81 USD
Diluted Eps TTM -1.81 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin -22.90 %

Dividend Analytics PRPO

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History PRPO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
Dividend CAGR 3Y
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
Forward Annual Dividend – USD
Last Split Factor 1:20
Payout Ratio
Last Split Date 22.09.2023

Stock Valuation PRPO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 15.43
Enterprise Value Revenue 0.51
Price Sales TTM 0.52
Enterprise Value EBITDA -1.15
Price Book MRQ 0.73

Financials PRPO

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators PRPO

For 52 weeks

4.31 USD 7.30 USD
50 Day MA 6.46 USD
Shares Short Prior Month 6 444
200 Day MA 6.05 USD
Short Ratio 0.59
Shares Short 4 613
Short Percent 0.35 %
Dividend information is being updated